---
title: "Longshenrongfa Pharmaceutical Industry: Currently no relevant business and expansion plans in the brain-computer interface field"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253373375.md"
description: "On August 18th, Longshenrongfa Pharmaceutical Industry stated on the interactive platform that the company focuses on the research, production, and sales of traditional Chinese medicine, and currently has no related business or expansion plans in the field of brain-machine interfaces"
datetime: "2025-08-18T01:13:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253373375.md)
  - [en](https://longbridge.com/en/news/253373375.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253373375.md)
generator: "portal-rs"
---

# Longshenrongfa Pharmaceutical Industry: Currently no relevant business and expansion plans in the brain-computer interface field

On August 18th, Longshenrongfa Pharmaceutical Industry stated on the interactive platform that the company focuses on the research, production, and sales of traditional Chinese medicine, and currently has no related business or expansion plans in the field of brain-machine interfaces

### Related Stocks

- [300534.CN](https://longbridge.com/en/quote/300534.CN.md)

## Related News & Research

- [RLO: Tripling revenue ambition, global defence focus, and innovation drive long-term growth](https://longbridge.com/en/news/297759336.md)
- [Istanbul Care Unveils All-Inclusive 2026 Hair Transplant Packages Featuring Fixed Pricing and Individualized Clinical Care](https://longbridge.com/en/news/297951968.md)
- [02:00 ETArgo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at Bradykinin Symposium 2026](https://longbridge.com/en/news/297995914.md)
- [Cupid share price in focus on board approval to set up manufacturing venture in South African](https://longbridge.com/en/news/297455298.md)
- [US FDA is working with manufacturers to boost estradiol patch supply amid access concerns](https://longbridge.com/en/news/297917790.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**